DAY 1
WEDNESDAY, DECEMBER 13
Program Moderator: Antonio Bianco, MD
Endocrine Section
10:00 a 13:00
Registration
13:00 a 13:10
Welcome to Curso XXV
Overview of the program
Jaime A. Davidson, MD, FACP, MACE
13:10 a 13:40
Jorge H. Mestman keynote lecture
A new approach to The treatment of hypothyroidism
Antonio Bianco, MD
13:40 a 13:50
Q&A
13:50 a 14:20
Hypercalcemia associated to malignacy. New guidelines
Mark Jara, MD, PhD
14:20 a 14:30
Q&A
14:30 a 15:00
Coffee break and informal discussion with faculty
15:00 a 15:30
Beyond papillary: What’s new with follicular and hurthle cell carcinoma?
Laura Boucai, MD
15:30 a 15:40
Q&A
15:40 a 16:10
News in the treatments of neuroendocrine tumors
Jaydira del Rivero, MD
16:10 a 16:20
Q&A
16:20 a 16:50
Immunecheck point inhibitors and endocrinopathies
Ricardo Correa, MD
16:50 a 17:00
Q&A
17:00 a 17:20
Endocrine tumors surgery. What the surgeon expects from the endocrinologist
Carmen Solorzano, MD
17:20 a 17:30
Q&A
17:30 a 17:45
Summary and review of next day activities
Antonio Bianco, MD
18:00 a 19:00
Satellite meeting or product theater
DAY 2
THURSDAY, DECEMBER 14
Program Moderator: Mark Jara, MD, PhD
Endocrine section
7:00 a 07:45
Continental breakfast. Satellite or product theater
07:45 a 08:00
Welcome and review of the day’s program
08:00 a 08:30
Topic TBD
Jaydira Del Rivero, MD
08:30 a 09:00
When to consider hemithyroidectomy?
Laura Boucai, MD & Carmen Solorzano, MD
09:00 a 09:15
Q&A
09:15 a 09:45
Cushings syndrome. Diagnosis and management 2023
Ricardo Correa, MD
09:45 a 10:00
Q&A
10:00 a 10:30
Coffee creak and informal discussion with faculty
10:30 a 11:00
Vaccines 2023. An update for patients with chronic endocrine conditions
Rosanna Rosa, MD
11:10 a 11:20
Q&A
11:25 a 12:30
Meet the proffesor:
1. Managing a patient with residual symptoms of hypothyroidism – Antonio Bianco, MD
2. Managing thyroid nodules – Laura Boucai, MD
3. Hypercalcemia in malignancy cases – Mark Jara, MD
4. Transgender cases – Ricardo Correa, MD
5. TBD – Jaydira del Rivero, MD
6. Cases of hyperparathyroidism – Carmen Solorazano, MD
12:30 a 13:30
Lunch. Product theater or satellite symposium
13:30 a 14:30
Workshops (repetition)
14:35 a 15:05
Epigenetics of thyroid hormone action: the new frontier.
Moderator: Laura Boucai, MD
Antonio Bianco, MD
15:05 a 15:15
Q&A
15:15 a 15:45
Coffee break and informal discussion with faculty
15:45 a 16:30
Case presentations from the audience
16:30 a 17:30
Symposium NIH
1. The NIH – Saul Malozovsky, MD
2. Opportunities for research in latinos – Larissa Aviles-Santa, MD
3. New treatment opportunities in neuroendocrine tumors – Jaydira del Rivero, MD
17:30 a 17:45
Summary and review of next day’s activities
Mark Jara, MD
17:45 a 18:00
Product theater or non-CME session
18:30 a 19:15
Fraternity reception
DAY 3
FRIDAY, DECEMBER 15
Program Moderator: Bartolomé Burguera, MD, PhD
Diabetes, Obesity and Cardiovascular Disease Section
7:00 a 07:45
Continental breakfast. Satellite session or product theater
07:45 a 07:55
Welcome and review of the day’s program
Jaime A. Davidson, MD, FACP, MACE
07:55 a 08:00
What the endocrinologist needs to know about cardiology
Mauricio Cohen, MD
08:00 a 08:25
Hypertension 101. Preventing collateral damage
Maria Delgado-Lelievre, MD
08:25 a 08:50
Heart failure and diabetes
Carolina Masri, MD
08:50 a 09:20
Cardiometabolic risk in hypertension. Not all patients with hypertension are the same
Maria Delgado-Lelievre, MD
09:20 a 09:45
Coronary heart disease and the patient with diabetes
Mauricio Cohen, MD
09:45 a 10:00
Panel discussion and questions
10:00 a 10:30
Coffee break and informal discussion with faculty
10:30 a 10:55
Diabetic foot. Diagnosis, prevention and treatment
Moderator: TBD
Rossana Rosa, MD
10:55 a 11:00
Q&A
11:00 a 11:25
What’s new in diabetes technology. ‘Continuous glucose monitoring’
Ingrid Libman, MD & Francisco Pasquel, MD, MPH
11:25 a 11:40
What’s new in diabetes technology. ‘The artificial pancreas’
Ingrid Libman, MD & Francisco Pasquel, MD, MPH
11:40 a 11:50
Q&A
11:55 a 12:55
Meet the professor:
1. Technology in diabetes, hands on – Ingrid Libman, MD & Francisco Pasquel, MD, MPH
2. Cases for GLP vs GLP combos – Juan P. Frias, MD
3. Obesity cases – Carolina Herrera-Solis, MD
4. Cases of CHF – Mauricio Cohen, MD
5. Cases of hypertension – Maria Delgado-Lalievre
6. Diabetic foot cases – Rossana Rosa, MD
12:55 a 13:50
Abbott product theater Rosemarie Lajara, MD
Lunch
13:50 a 14:50
Workshops (repeated)
14:55 a 15:20
Nephropathy in youth and young adults with T2DM or therapeutic manipulation of myocardial metabolism. State-of-the-art-review
Carolina Herrera-Solis, MD
15:20 a 15:30
Q&A
15:30 a 15:50
Coffee break and informal discussion with faculty
15:50 a 16:15
Incretin based therapies: Current practice and future developments. Do we need more than such combos?
Juan P. Frias, MD
16:15 a 16:20
Q&A
16:20 a 17:50
News on clinical trials, new drugs in develompent, pipelines. New devices, etc.
Moderator: Jaime A. Davidson, MD
Daniel Chernavsky, MD DEXCOM & Douglas Barbieri, MD Abbott
17:50 a 18:00
Q&A
18:00 a 18:15
Summary and review of next day’s activities
Jaime A. Davidson, MD o Francisco Pasquel, MD, MPH
DAY 4
SATURDAY, DECEMBER 16
Program Moderador: TBD, MD
Diabetes, Obesity and Cardiovascular Disease Section
7:00 a 07:45
Continental breakfast
08:00 a 08:10
Welcome and review of the day’s program
Jaime A. Davidson, MD
08:10 a 09:30
Recent clinical trials. Cardiovascular, renal, lipids, diabetes prevention, etc.
Moderator: TBD
Participants:
Ingrid Libman, MD
Carolina Herrera-Solis, MD
Francisco Pasquel, MD, MPH
Juan Pablo Frias, MD
Ricardo Correa, MD
Maria Delgado-Lelievre, MD
Mauricio Cohen, MD
09:30 a 10:00
Leptin for the clinical endocrinologist
Saul Malozowski, MD
10:00 a 10:10
Q&A
10:10 a 10:30
Coffee break and informal discussion with faculty
10:30 a 11:00
Weekly basal insulin. A review of MOA, efficacy and safety
Juan Pablo Frias, MD
11:00 a 11:10
Q&A
11:10 a 11:40
New insights into the pathophysiology of obesity. Can we match pharmacological interventions?
Carolina Herrera-Solis, MD
11:40 a 11:50
Q&A
11:50 a 12:20
2023 Guidelines updates: Everything you wanted to know
Francisco Pasquel, MD, MPH
12:20 a 12:30
Q&A
12:30 a 12:40
Final observations and announcement of the 2024 Course
December 11-14, 2024
Jaime A. Davidson, MD, FACP, MACE
